Acetylsalicylic acid Completed Phase 2 Trials for Critical Limb Ischemia (CLI) Prevention

IndicationsStatusPurposePhase
CompletedPrevention2
clinicaltrials.gov IdentifierTitleDrugs
NCT02260622Pilot Study to Examine the Use of Rivaroxaban After Angioplasty for Critical Limb Ischemia